
Fusion Pharmaceuticals Investor Relations Material
Latest events

Study Update
Fusion Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Fusion Pharmaceuticals Inc
Access all reports
Fusion Pharmaceuticals Inc. is a clinical-stage oncology company headquartered in Hamilton, Canada, focusing on the development of radiopharmaceuticals as precision medicines. The company's primary efforts are directed towards developing treatments that utilize alpha particle emitting isotopes to selectively target and destroy tumor cells. Fusion Pharmaceuticals leverages its Targeted Alpha Therapies (TAT) platform, which facilitates the connection of these isotopes to various targeting molecules, aiming to deliver alpha particle payloads directly to tumors. This approach underpins its research and insights into the chemistry and biology of alpha-emitting radiopharmaceuticals, alongside its capabilities in target identification, candidate generation, manufacturing, and supply chain. Its shares are listed on the Nasdaq.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
FUSN
Country
🇨🇦 Canada